POINT Biopharma Global Inc., (PNT) Social Stream



POINT Biopharma Global Inc., (PNT): $8.10

0.15 (+1.89%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PNT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

POINT BIOPHARMA GLOBAL INC (PNT) Price Targets From Analysts

Use the tables below to see what analysts covering POINT BIOPHARMA GLOBAL INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 3 $17 $8 $12.5 $7.38 69.38%
2021-12-06 4 $23 $8 $16 $7.38 116.8%
2022-05-13 5 $65 $8 $28.25 $7.38 282.79%
2022-05-31 5 $65 $14 $30.5 $7.38 313.28%
2022-08-12 6 $65 $14 $30.5 $7.38 313.28%
2022-08-15 7 $65 $14 $30.5 $7.38 313.28%
2022-08-16 7 $65 $14 $28.4 $7.38 284.82%
2022-09-14 9 $65 $19 $28.166 $7.38 281.65%
2022-09-16 9 $65 $19 $27.285 $7.38 269.72%
2022-09-18 9 $65 $17 $27 $7.38 265.85%
2022-09-19 9 $65 $17 $27.428 $7.38 271.65%
2022-11-09 10 $65 $17 $26.5 $7.38 259.08%
2022-11-15 10 $65 $14 $25 $7.38 238.75%
2022-11-16 10 $65 $12 $23.375 $7.38 216.73%
2022-11-21 10 $65 $12 $23.75 $7.38 221.82%
2022-11-30 11 $65 $12 $22.666 $7.38 207.13%
2022-12-14 11 $28 $10 $16.555 $7.38 124.32%

The Trend in the Analyst Price Target


Over the past 86 days, PNT's average price target has gone down $6.03.

Over the past 45 weeks, PNT's average upside potential has been 260.58%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-01 5 65 8 28.250 6.55 331.3%
2022-03-27 5 65 8 28.250 6.76 317.9%
2022-05-09 5 65 8 28.250 7.23 290.73%
2022-05-26 5 65 14 30.500 7.91 285.59%
2022-09-16 9 65 19 27.285 9.00 203.17%

PNT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.09 10 1 0 0 0 11

The Trend in the Broker Recommendations


PNT's average broker recommendation rating improved by 0.71 over the prior 31 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how POINT BIOPHARMA GLOBAL INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2069.87% of that group.
  • In the context of all US stocks, POINT BIOPHARMA GLOBAL INC's upside potential (average analyst target price relative to current price) is higher than 1963.57% of them.
  • PNT has a higher number of analysts covering the stock than 1867.54% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, POINT BIOPHARMA GLOBAL INC's average analyst price target is higher than 1357.8% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to POINT BIOPHARMA GLOBAL INC are IVA, ANNX, and NRIX.

What is the outlook for PNT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6169 seconds.